The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells.
The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells.
复制标题
DOI:
10.1084/jem.20011838
复制
发表时间:
2002-08-05
期刊:
影响因子:
--
通讯作者:
Goulmy E
中科院分区:
文献类型:
--
作者:
Klein CA;Wilke M;Pool J;Vermeulen C;Blokland E;Burghart E;Krostina S;Wendler N;Passlick B;Riethmüeller G;Goulmy E
Allogeneic stem cell transplantation (SCT) can induce curative graft-versus-tumor reactions in patients with hematological malignancies and solid tumors. The graft-versus-tumor reaction after human histocompatibility leukocyte antigen (HLA)-identical SCT is mediated by alloimmune donor T cells specific for polymorphic minor histocompatibility antigens (mHags). Among these, the mHag HA-1 was found to be restricted to the hematopoietic system. Here, we report on the HA-1 ribonucleic acid expression by microdissected carcinoma tissues and by single disseminated tumor cells isolated from patients with various epithelial tumors. The HA-1 peptide is molecularly defined, as it forms an immunogenic peptide ligand with HLA-A2 on the cell membrane of carcinoma cell lines. HA-1–specific cytotoxic T cells lyse epithelial tumor cell lines in vitro, whereas normal epithelial cells are not recognized. Thus, HA-1–specific immunotherapy combined with HLA-identical allogeneic SCT may now be feasible for patients with HA-1+ carcinomas.
登录
查看更多内容
影响因子:
3.2
作者:
VANELS, CACM;DAMARO, J;GOULMY, E
通讯作者:
GOULMY, E
影响因子:
20.3
作者:
Eibl, B;Schwaighofer, H;Niederwieser, D
通讯作者:
Niederwieser, D
影响因子:
32.4
作者:
BOEL, P;WILDMANN, C;VANDERBRUGGEN, P
通讯作者:
VANDERBRUGGEN, P
影响因子:
20.3
作者:
Mutis, T;Verdijk, R;Goulmy, E
通讯作者:
Goulmy, E
影响因子:
15.3
作者:
FALKENBURG, JHF;GOSELINK, HM;GOULMY, E
通讯作者:
GOULMY, E